Skip to main content

Glipizide

NDC 52817-385 · TruPharma LLC

Generic nameGlipizide
Dosage formTABLET
RouteORAL
Active ingredient(s)GLIPIZIDE
Strength2.5 mg/1
Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]
Marketing categoryANDA

Packages

52817-385-10 — 100 TABLET in 1 BOTTLE (52817-385-10)

52817-385-50 — 500 TABLET in 1 BOTTLE (52817-385-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-7908 — Glipizide, 50268-361 — Glipizide, 50268-362 — Glipizide, 51407-620 — Glipizide, 51407-621 — Glipizide, 51655-106 — Glipizide, 51655-180 — Glipizide, 51655-337 — Glipizide, 51655-810 — Glipizide, 51655-966 — Glipizide, 55154-7987 — Glipizide, 55289-806 — Glipizide, 59651-780 — Glipizide, 59651-781 — Glipizide, 59651-782 — Glipizide, 60505-0141 — Glipizide, 60505-0142 — Glipizide, 60687-690 — Glipizide, 60687-701 — Glipizide, 60687-768 — Glipizide, +132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels